These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 229941

  • 1. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA, Markandu ND, Roulston JE, Jones JC.
    Br Med J; 1979 Nov 03; 2(6198):1106-9. PubMed ID: 229941
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K, Shigetomi S, Haruyama K, Matsui J, Gotho M, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1980 Jan 03; 22(1):1-11. PubMed ID: 6247526
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982 Jan 03; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

  • 5. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep 03; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 6. Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.
    Campbell BC, Shepherd AN, Reid JL.
    Br J Clin Pharmacol; 1982 Feb 03; 13(2):213-7. PubMed ID: 6277356
    [Abstract] [Full Text] [Related]

  • 7. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP, Karlberg BE, Nilsson OR, Wettre S.
    Acta Med Scand Suppl; 1981 Feb 03; 646():98-105. PubMed ID: 7018190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G, Alicandri CL, Agabiti-Rosei E, Fariello R, Beschi M, Boni E, Castellano M, Moniti E, Muiesan L, Romanelli G, Zanielli A.
    Am J Cardiol; 1982 Apr 21; 49(6):1420-4. PubMed ID: 6280474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P, Genest J, Kuchel O, Boucher R, Gutkowska Y, McKinstry D.
    Can Med Assoc J; 1979 Aug 04; 121(3):309-16. PubMed ID: 223756
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A, Aguglia F, De Mattia G, Ficara C, Balsano F.
    Br J Clin Pharmacol; 1982 Aug 04; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A, Stumpe KO, Heck I, Krück F.
    Dtsch Med Wochenschr; 1980 Apr 11; 105(15):505-9. PubMed ID: 6244920
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.